Evidence map›Paper›PMID 35075692›Full record

ArticleJournal of leukocyte biology2022

TREM-1 is required for enhanced OpZ-induced superoxide generation following priming.

Shubha Murthy, Sankar Baruah, Jayden L Bowen, Kathy Keck, Brett A Wagner, Garry R Buettner, David B Sykes, Julia Klesney-Tait

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 52% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 3 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Shubha MurthyDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Sankar BaruahDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Jayden L BowenDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Kathy KeckDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Brett A WagnerFree Radical and Radiation Biology Program, Department of Radiation Oncology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.
Garry R BuettnerFree Radical and Radiation Biology Program, Department of Radiation Oncology, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.ORCID 0000-0002-5594-1903
David B SykesCenter for Regenerative Medicine, Massachusetts General Hospital, Boston and Harvard Stem Cell Institute, Cambridge, Massachusetts, USA.
Julia Klesney-TaitDepartment of Internal Medicine, University of Iowa Carver College of Medicine, Iowa City, Iowa, USA.ORCID 0000-0002-0261-8395
University of Iowa · USMassachusetts General Hospital · US

Funding

Viral VectorP30CA086862 · NCI · UNIVERSITY OF IOWA · PI Christopher K Laubenthal · 2000 to 2026
$70.0M
Pulmonary Toxicology Facility CoreP30ES005605 · NIEHS · UNIVERSITY OF IOWA · PI Jong Sung Kim · 1990 to 2026
$40.5M
Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
Project 3: MRI Imaging of Redox Active Fe Predicts GBM Responses to Pharmacological AscorbateP01CA217797 · NCI · UNIVERSITY OF IOWA · PI SPITZ, DOUGLAS ROBERT · 2018 to 2022
$9.6M
The Role of TREM-1 in Neutrophil Transepithelial MigrationR01HL121105 · NHLBI · UNIVERSITY OF IOWA · PI KLESNEY-TAIT, JULIA A · 2015 to 2019
$1.9M
Developing differentiation therapy for the treatment of patients with acute myeloid leukemiaK08CA201640 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI SYKES, DAVID B · 2017 to 2020
$677k
NCI NIH HHS K08 CA201640NCI NIH HHS P01 CA217797NCI NIH HHS P30 CA086862NHLBI NIH HHS R01 HL121105NIDDK NIH HHS P30 DK054759NIEHS NIH HHS P30 ES005605
6 · The paper itself

Abstract

Inflammatory agents, microbial products, or stromal factors pre-activate or prime neutrophils to respond to activating stimuli in a rapid and aggressive manner. Primed neutrophils exhibit enhanced chemotaxis, phagocytosis, and respiratory burst when stimulated by secondary activating stimuli. We previously reported that Triggering Receptor Expressed on Myeloid cells-1 (TREM-1) mediates neutrophil effector functions such as increased superoxide generation, transepithelial migration, and chemotaxis. However, it is unclear whether TREM-1 is required for the process of priming itself or for primed responses to subsequent stimulation. To investigate this, we utilized in vitro and in vivo differentiated neutrophils that were primed with TNF-α and then stimulated with the particulate agonist, opsonized zymosan (OpZ). Bone marrow progenitors isolated from WT and Trem-1

Indexed as

Respiratory BurstSuperoxidesAnimalsMiceNeutrophilsTriggering Receptor Expressed on Myeloid Cells-1ZymosanSuperoxidesTREM1 protein, mouseTriggering Receptor Expressed on Myeloid Cells-1ZymosanEPR spectroscopyER-Hoxb8 neutrophilsreceptorsTNF-α

Identifiers

PMID35075692
PMCPMC9308838
OpenAlexW4207052555

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.